Showing results (1411-1420 of 1,447) with videos related to
Sort By:
Pageof 145
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast CancerAngela DeMichele, Douglas Yee, Donald A Berry, et al.JAMA Oncology|February 14, 2020
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 TrialRita Nanda, Minetta C Liu, Christina Yau, et al.NPJ Parkinson'S Disease|May 14, 2026
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohortsXiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, et al.Infection Control and Hospital Epidemiology|May 21, 2024
Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020-December 2021Nora Chea, Taniece Eure, Rebecca Alkis Ramirez, et al.Nature Genetics|November 17, 2009
Genome-wide association study reveals genetic risk underlying Parkinson's diseaseJavier Simón-Sánchez, Claudia Schulte, Jose M Bras, et al.Human Genetics|July 1, 2008
Replication of association between ELAVL4 and Parkinson disease: the GenePD studyAnita L DeStefano, Jeanne Latourelle, Mark F Lew, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD studyChristopher F McNicoll, Jeanne C Latourelle, Marcy E MacDonald, et al.The New England Journal of Medicine|July 14, 2016
Adaptive Randomization of Neratinib in Early Breast CancerJohn W Park, Minetta C Liu, Douglas Yee, et al.Cancer Cell|June 18, 2021
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trialLajos Pusztai, Christina Yau, Denise M Wolf, et al.Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome SequencingMirja Thomsen, Fabian Ott, Sebastian Loens, et al.Pageof 145